Medicare Enrolled
Dr. Hany Guirgis, M.D
Cardiovascular Disease · Melbourne, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Guirgis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guirgis? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guirgis
Dr. Hany Guirgis is a cardiovascular disease in Melbourne, FL, with 19 years in practice. Based on federal Medicare data, Dr. Guirgis performed 10,333 Medicare services across 6,589 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guirgis received a total of $10,445 from 40 pharmaceutical and/or device companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guirgis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 7% volume in FL$ $10,445 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,333
Medicare services
Top 7% in FL for cardiovascular disease
6,589
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~544 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,927 | $89 | $259 |
| Electrocardiogram (EKG), 12-lead | 993 | $10 | $30 |
| Hospital follow-up visit, moderate complexity | 869 | $63 | $144 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 637 | $18 | $54 |
| Echocardiogram, transthoracic | 578 | $138 | $493 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 569 | $28 | $87 |
| Initial hospital admission, high complexity | 405 | $137 | $402 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 328 | $88 | $306 |
| Office visit, established patient, complex (40-54 min) | 312 | $129 | $363 |
| Regadenoson injection (Lexiscan) for heart stress test | 298 | $40 | $105 |
| New patient office visit (45-59 min) | 226 | $112 | $338 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 182 | $303 | $1,065 |
| Hospital follow-up visit, high complexity | 180 | $94 | $207 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 174 | $136 | $474 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 167 | $48 | $175 |
| Ultrasound of both sides of head and neck blood flow | 166 | $135 | $468 |
| Remote pacemaker/defibrillator monitoring, 90 days | 115 | $16 | $51 |
| Remote pacemaker monitoring, 90 days | 110 | $23 | $69 |
| New patient office visit, complex (60-74 min) | 92 | $159 | $447 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 86 | $20 | $54 |
| Cardiac catheterization | 86 | $206 | $777 |
| Programming of dual lead pacemaker system | 79 | $27 | $78 |
| Office visit, established patient (20-29 min) | 73 | $61 | $183 |
| Programming of cardiac rhythm monitor system | 58 | $21 | $52 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 54 | $51 | $180 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 52 | $19 | $51 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 52 | $89 | $300 |
| Ultrasound of leg arteries or artery grafts | 49 | $177 | $484 |
| Insertion of heart rhythm monitor under skin | 47 | $3,204 | $12,230 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $83 | $273 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $2 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 45 | $14 | $45 |
| Coronary stent placement | 31 | $450 | $1,571 |
| Critical care, first 30-74 min | 28 | $170 | $553 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 24 | $627 | $1,291 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 23 | $9 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $20 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $16 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $11 | $30 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 15 | $747 | $2,672 |
| Ultrasound of heart, follow-up | 15 | $19 | $52 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $212 | $770 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $287 | $989 |
| New patient office visit (30-44 min) | 11 | $80 | $226 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.7% high complexity
11.6% medium
77.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,445
Total received (2018-2024)
Avg $1,492/year across 7 years
Top 24% in FL for cardiovascular disease
40
Companies
367
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,445 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,815
2023$868
2022$1,621
2021$1,011
2020$1,052
2019$892
2018$1,184
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$2,218
Janssen Pharmaceuticals, Inc
$895
AstraZeneca Pharmaceuticals LP
$725
ABIOMED
$654
Amgen Inc.
$642
Medical Device Business Services, Inc.
$582
Novartis Pharmaceuticals Corporation
$506
ShockWave Medical, Inc
$472
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$412
Medtronic, Inc.
$383
SANOFI-AVENTIS U.S. LLC
$381
Boehringer Ingelheim Pharmaceuticals, Inc.
$255
Amarin Pharma Inc.
$204
Novo Nordisk Inc
$191
E.R. Squibb & Sons, L.L.C.
$188
PFIZER INC.
$161
Biosense Webster, Inc.
$155
Abbott Laboratories
$144
Lexicon Pharmaceuticals, Inc.
$112
Impulse Dynamics (USA) Inc.
$110
AngioDynamics, Inc.
$109
CVRx, Inc.
$108
Edwards Lifesciences Corporation
$108
Astellas Pharma US Inc
$103
BOSTON SCIENTIFIC CORPORATION
$88
Baylis Medical Company Inc
$84
BIOTRONIK INC.
$75
Medtronic Vascular, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$66
Boston Scientific Corporation
$65
Kowa Pharmaceuticals America, Inc.
$27
CHIESI USA, INC.
$23
Merck Sharp & Dohme LLC
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$16
Bardy Diagnostics, Inc.
$15
SCPHARMACEUTICALS INC.
$15
Cardiovascular Systems Inc.
$13
Lundbeck LLC
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 36.7% of total payments
Associated products mentioned in payments ›
AURYON LASER SYSTEM 100-120 VAC · Adempas · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARTO 3 · CHANTIX · CLOSUREFAST · COBALT DR MRI SURESCAN · CONFIRM RX · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · HawkOne · HeartWare HVAD · Impella · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · Micra · NA · NORTHERA · Optimizer · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · RESOLUTE ONYX · REVEAL LINQ · Repatha · Reveal LINQ · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Thermocool SF · Tresiba · VERQUVO · Vascepa · VersaCross Access Solution · Victoza · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $101 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
39
Per 100K population
6.3
County median income
$75,817
Nearest hospital
VIERA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Guirgis is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Guirgis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Guirgis performed 2,927 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guirgis receive payments from pharmaceutical companies?
Yes. Dr. Guirgis received a total of $10,445 from 40 companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guirgis's costs compare to other cardiovascular diseases in Melbourne?
Dr. Guirgis's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guirgis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Melbourne
Browse cardiovascular diseases in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology